Alopecia Areata. Alopecia areata
Conditions
Interventions
Intervention 1: Intervention group: Group A will be given Tofacitinib 5 mg (twice daily) for three months. Intervention 2: Intervention group: Group B Patients will receive oral prednisolone 0.5 mg/Kg
Sponsors
Combined Military Hospital, Quetta, Pakistan
Eligibility
Sex/Gender
All
Age
15 Years to 59 Years
Inclusion criteria
Inclusion criteria: Clinical diagnosis of alopecia areata with SALT score of 25 % or more Age Range 15-59 years Patients who have not taken oral, topical or systemic treatment for alopecia areata within 3 months prior to study
Exclusion criteria
Exclusion criteria: History of severe systemic diseases (Hepatic, renal, pulmonary and cardiovascular) Pregnant or nursing mother Those with other causes of hair loss; androgenetic alopecia, telogen effluvium, trichotillomania and cicatricial alopecia Hypersensitivity to medications Patients who are immunodeficient or undergoing immunosuppressive therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in SALT score from baseline. Timepoint: Before intervention, 2, 6,10 and 12th week. Method of measurement: Clinical Examination and recording SALT score. | — |
Countries
Pakistan
Contacts
Public ContactRABBIA TARIQ
Combined Military Hospital, Quetta, Pakistan
Outcome results
None listed